Skip to main content
Toggle navigation
Search
Home
Back
Tweet
Tommer Mark
Poster(s):
P-408: Survival Analysis of Selinexor-Exposed Relapsed/Refractory Multiple Myeloma (RRMM) Treated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Real-World Exploratory Analysis
Wednesday, September 25, 2024